CMS issues standards for electronic exchange of medical records
The rule is intended to replace manual documentation processes — such as faxing, mailing, and payer specific portals — with standardized electronic transaction…
CMS proposes expanding prior authorization regulations to drugs
CMS is proposing an important expansion of its 2024 final rule that establishes an electronic prior authorization process to include drugs covered under a medi…
Understanding Medicare’s Medically Unlikely Edits
Allergists should be aware of the following MUEs associated with commonly billed CPT codes and the following MUE Adjudication Indicators.
Coding conundrum – billing options if vials must be remixed
The Advocacy Council regularly receives queries from members on how to correctly code specific scenarios. Here is a recent request.
Reimbursement challenges for allergy/immunotherapy services remain a problem
ACAAI’s Advocacy Council has made addressing these issues a top priority through our Payer Education Campaign and related initiatives
2026 HIPAA updates
This update provides members with a high-level overview with specific considerations for allergy and immunology practices.
College State Delegate Job Description
State Delegates serve as the liaisons between local, state and regional societies; the Super Delegates in their region; and HOD leadership.
College Super Delegate Job Description
College-appointed Super Delegates serve as the conduit between delegates, regional societies and the HOD leadership.
Advocacy Council fights for you on Capitol Hill
Members of the ACAAI Advocacy Council were on Capitol Hill fighting for issues important to allergy practices last week.
New proposed Medicare drug pricing models are unveiled
The College emphasizes that while fair pricing is essential, policies mustn't compromise drug availability or stifle research into new therapies.
We’re defending and empowering allergists
The ACAAI is the only allergy organization backed by Washington-based experts and consultants whose primary focus is allergy/immunology.
ACAAI applauds the latest expansion of GME slots
CMS announced the distribution of 400 new federally funded graduate medical education residency positions to hospitals across the country.
Medicare payment policies expire again
A brief lapse in funding is unlikely to trigger a full government shutdown of the agencies funded by the minibus
Claim denials for CPT code 95165 are growing
These requirements can significantly impact allergy practices that rely on preparing customized, multi-dose vials in advance.
The Senate HELP Committee seeks answers on CPT codes and coverage policies
Sen. Cassidy’s Request for Information (RFI) asks for specific data on the AMA’s licensing and royalty fees.
Issue with federal BCBS coverage of Xolair for IgE-mediated food allergy
Reports from members indicate that the FEP is denying coverage for Xolair unless the patient demonstrates confirmed allergies to peanuts plus at least two othe…
Food allergy testing guidance and coding
The cornerstone of effective food allergy diagnosis is a thorough clinical history.
Medicare denials for immunotherapy injections with venom immunotherapy
This issue began appearing last fall, affecting multiple Medicare Administrative Contractors (MACs). Denials typically cite reason code CO-50.
Congress passes ACAAI-backed Protecting Children with Food Allergies Act
This legislation represents an important step toward improving the safety and well-being of students with food allergies across the country.
